In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin

Carl Rosenblad, M Gronborg, C Hansen, N Blom, M Meyer, J Johansen, L Dago, Deniz Kirik, U A Patel, Cecilia Lundberg, D Trono, A Bjorklund, T E Johansen

Research output: Contribution to journalArticlepeer-review

Abstract

The glial cell line-derived neurotrophic factor (GDNF)-family of neurotrophic factors consisted until recently of three members, GDNF, neurturin, and persephin. We describe here the cloning of a new GDNF-family member, neublastin (NBN), identical to artemin (ART), recently published (Baloh et al., 1998). Addition of NBN/ART to cultures of fetal mesencephalic dopamine (DA) neurons increased the number of surviving tyrosine hydroxylase (TH)-immunoreactive neurons by approximately 70%, similar to the maximal effect obtained with GDNF. To investigate the neuroprotective effects in vivo, lentiviral vectors carrying the cDNA for NBN/ART or GDNF were injected into the striatum and ventral midbrain. Three weeks after an intrastriatal 6-hydroxydopamine lesion only about 20% of the nigral DA neurons were left in the control group, while 80-90% of the DA neurons remained in the NBN/ART and GDNF treatment groups, and the striatal TH-immunoreactive innervation was partly spared. We conclude that NBN/ART, similarly to GDNF, is a potent neuroprotective factor for the nigrostriatal DA neurons in vivo.
Original languageEnglish
Pages (from-to)199-214
JournalMolecular and Cellular Neuroscience
Volume15
Issue number2
DOIs
Publication statusPublished - 2000

Subject classification (UKÄ)

  • Neurosciences

Fingerprint

Dive into the research topics of 'In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin'. Together they form a unique fingerprint.

Cite this